Free Trial
→ DOGE Social Security bombshell? (From Altimetry) (Ad) Buy VCEL Stock  Free VCEL Stock Alerts

Vericel (VCEL) Financials

Vericel logo
$41.90 -2.34 (-5.29%)
Closing price 04:00 PM Eastern
Extended Trading
$41.88 -0.02 (-0.06%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Vericel

Annual Income Statements for Vericel

This table shows Vericel's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -16 -20 -17 -8.14 -9.67 2.86 -7.47 -17 -3.18 10
Consolidated Net Income / (Loss)		 -16 -20 -17 -8.14 -9.67 2.86 -7.47 -17 -3.18 10
Net Income / (Loss) Continuing Operations		 -16 -20 -17 -8.14 -9.67 2.86 -7.47 -17 -3.18 10
Total Pre-Tax Income 		-16 -20 -17 -8.14 -9.67 3.04 -7.58 -16 -2.37 11
Total Operating Income		 -17 -19 -15 -3.91 -11 2.37 -7.85 -17 -6.46 4.52
Total Gross Profit		 25 26 34 59 80 84 106 110 136 172
Total Revenue		 51 54 64 91 118 124 156 164 198 237
Operating Revenue		 51 54 63 91 118 124 156 164 198 237
Total Cost of Revenue		 26 28 30 32 38 40 50 55 62 65
Operating Cost of Revenue		 26 28 30 32 38 40 50 55 62 65
Total Operating Expenses		 41 45 49 63 92 82 114 127 142 168
Selling, General & Admin Expense		 22 27 36 49 61 69 98 107 121 143
Research & Development Expense		 19 15 13 14 30 13 16 20 21 25
Total Other Income / (Expense), net		 0.33 -0.32 -2.30 -4.23 1.59 0.67 0.27 1.07 4.10 5.99
Interest Expense		 0.01 0.02 0.95 0.87 0.01 0.01 0.00 0.37 0.60 0.61
Interest & Investment Income		 0.04 0.01 0.01 0.90 1.61 0.69 0.22 1.34 4.63 6.41
Other Income / (Expense), net		 0.30 -0.31 -1.36 -4.26 -0.02 -0.01 0.05 0.10 0.06 0.20
Income Tax Expense		 - - - 0.00 0.00 0.18 -0.11 0.72 0.81 0.15
Basic Earnings per Share		 ($0.97) ($1.18) ($0.52) ($0.20) ($0.22) $0.06 ($0.16) ($0.35) ($0.07) $0.21
Weighted Average Basic Shares Outstanding		 23.76M 23.09M 33.36M 40.24M 44.18M 45.22M 46.47M 47.13M 47.59M 48.85M
Diluted Earnings per Share		 ($0.97) ($1.18) ($0.52) ($0.20) ($0.22) $0.06 ($0.16) ($0.35) ($0.07) $0.20
Weighted Average Diluted Shares Outstanding		 23.76M 23.09M 33.36M 40.24M 44.18M 47.28M 46.47M 47.13M 47.59M 51.68M
Weighted Average Basic & Diluted Shares Outstanding		 23.76M 23.09M 33.36M 40.24M 44.18M 45.95M 46.97M 47.36M 48.29M 49.97M

Quarterly Income Statements for Vericel

This table shows Vericel's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 -6.58 5.92 -7.50 -5.02 -3.66 13 -3.86 -4.68 -0.90 20
Consolidated Net Income / (Loss)		 -6.58 5.92 -7.50 -5.02 -3.66 13 -3.86 -4.68 -0.90 20
Net Income / (Loss) Continuing Operations		 -6.58 5.92 -7.50 -5.02 -3.66 13 -3.86 -4.68 -0.90 20
Total Pre-Tax Income 		-6.56 6.62 -7.50 -5.02 -3.95 14 -3.86 -4.68 -0.90 20
Total Operating Income		 -6.79 6.09 -8.18 -5.96 -5.06 13 -5.46 -6.03 -2.47 18
Total Gross Profit		 25 38 27 30 31 49 35 37 42 58
Total Revenue		 39 53 41 46 46 65 51 53 58 75
Operating Revenue		 39 53 41 46 46 65 51 53 58 75
Total Cost of Revenue		 13 14 14 16 15 16 16 16 16 17
Operating Cost of Revenue		 13 14 14 16 15 16 16 16 16 17
Total Operating Expenses		 32 32 35 36 36 36 41 43 44 40
Selling, General & Admin Expense		 27 27 29 31 30 31 34 35 38 35
Research & Development Expense		 5.05 5.25 5.21 5.25 5.68 4.90 6.42 7.36 6.09 4.92
Total Other Income / (Expense), net		 0.23 0.54 0.68 0.94 1.11 1.36 1.60 1.35 1.56 1.48
Interest Expense		 0.11 0.22 0.15 0.15 0.15 0.16 0.15 0.15 0.15 0.15
Interest & Investment Income		 0.34 0.76 0.84 1.10 1.26 1.44 1.76 1.51 1.58 1.56
Other Income / (Expense), net		 -0.01 -0.00 -0.01 -0.01 -0.00 0.08 -0.01 -0.01 0.14 0.07
Basic Earnings per Share		 ($0.14) $0.13 ($0.16) ($0.11) ($0.08) $0.28 ($0.08) ($0.10) ($0.02) $0.41
Weighted Average Basic Shares Outstanding		 47.18M 47.13M 47.39M 47.57M 47.65M 47.59M 48.14M 48.69M 49.09M 48.85M
Diluted Earnings per Share		 ($0.14) $0.13 ($0.16) ($0.11) ($0.08) $0.28 ($0.08) ($0.10) ($0.02) $0.40
Weighted Average Diluted Shares Outstanding		 47.18M 47.13M 47.39M 47.57M 47.65M 47.59M 48.14M 48.69M 49.09M 51.68M
Weighted Average Basic & Diluted Shares Outstanding		 47.22M 47.36M 47.56M 47.64M 47.72M 48.29M 48.60M 49.03M 49.36M 49.97M

Annual Cash Flow Statements for Vericel

This table details how cash moves in and out of Vericel's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 -16 8.40 3.88 -8.58 8.69 6.85 35 -17 36 -1.82
Net Cash From Operating Activities		 -13 -20 -13 -0.41 -7.18 18 29 18 35 58
Net Cash From Continuing Operating Activities		 -13 -20 -13 -0.41 -7.18 18 29 18 35 58
Net Income / (Loss) Continuing Operations		 -16 -20 -17 -8.14 -9.67 2.86 -7.47 -17 -3.18 10
Consolidated Net Income / (Loss)		 -16 -20 -17 -8.14 -9.67 2.86 -7.47 -17 -3.18 10
Depreciation Expense		 1.59 1.89 1.61 1.43 1.74 2.38 2.97 3.98 4.63 5.50
Amortization Expense		 - 0.00 0.00 -0.33 -0.61 0.32 0.95 0.20 -0.61 -0.44
Non-Cash Adjustments To Reconcile Net Income		 2.81 5.14 3.72 11 13 14 36 39 41 51
Changes in Operating Assets and Liabilities, net		 -1.41 -7.35 -1.23 -4.03 -12 -2.42 -3.07 -8.68 -6.48 -7.97
Net Cash From Investing Activities		 -2.39 -1.42 -1.51 -67 11 -17 -3.50 -36 -3.13 -79
Net Cash From Continuing Investing Activities		 -2.39 -1.42 -1.51 -67 11 -17 -3.50 -36 -3.13 -79
Purchase of Property, Plant & Equipment		 -2.43 -1.42 -1.51 -2.68 -2.62 -2.63 -7.92 -7.60 -20 -64
Acquisitions		 - - - - - - 0.00 0.00 -7.50 0.00
Purchase of Investments		 - 0.00 0.00 -67 -72 -63 -60 -70 -55 -68
Sale and/or Maturity of Investments		 - 0.00 0.00 2.20 86 49 64 41 80 53
Net Cash From Financing Activities		 -0.02 30 19 59 5.26 6.44 9.17 1.05 3.62 19
Net Cash From Continuing Financing Activities		 -0.02 30 19 59 5.26 6.44 9.17 1.05 3.62 19
Repayment of Debt		 -0.04 -2.65 -8.65 -18 - -0.03 -0.35 -0.04 -0.04 0.00
Issuance of Debt		 - 13 15 - -0.03 0.00 0.00 -1.08 0.00 0.00
Other Financing Activities, net		 0.00 0.00 12 7.08 5.29 6.47 9.52 2.16 3.66 19
Cash Interest Paid		 - - - - 0.01 0.01 0.00 0.11 0.38 0.40
Cash Income Taxes Paid		 - - - - 0.08 0.15 0.38 0.00 1.17 0.63

Quarterly Cash Flow Statements for Vericel

This table details how cash moves in and out of Vericel's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 2.98 -14 11 8.98 13 3.31 -16 5.11 -5.50 15
Net Cash From Operating Activities		 4.10 6.98 7.86 10 7.17 10 7.20 19 10 22
Net Cash From Continuing Operating Activities		 4.10 6.98 7.86 10 7.17 10 7.20 19 10 22
Net Income / (Loss) Continuing Operations		 -6.58 5.92 -7.50 -5.02 -3.66 13 -3.86 -4.68 -0.90 20
Consolidated Net Income / (Loss)		 -6.58 5.92 -7.50 -5.02 -3.66 13 -3.86 -4.68 -0.90 20
Depreciation Expense		 1.01 1.04 1.16 1.17 1.15 1.15 1.38 1.32 1.33 1.48
Amortization Expense		 0.04 -0.14 -0.24 -0.16 -0.23 0.02 -0.05 -0.21 -0.12 -0.06
Non-Cash Adjustments To Reconcile Net Income		 10 8.34 9.86 9.94 11 9.81 12 11 11 17
Changes in Operating Assets and Liabilities, net		 -0.41 -8.18 4.58 4.27 -1.44 -14 -1.88 11 -1.01 -16
Net Cash From Investing Activities		 -0.81 -22 2.80 -2.41 4.57 -8.09 -25 -18 -21 -15
Net Cash From Continuing Investing Activities		 -0.81 -22 2.80 -2.41 4.57 -8.09 -25 -18 -21 -15
Purchase of Property, Plant & Equipment		 -1.41 -1.13 -1.41 -4.20 -6.57 -7.84 -14 -17 -19 -14
Purchase of Investments		 -9.00 -26 -9.79 -19 -7.72 -19 -23 -13 -17 -16
Sale and/or Maturity of Investments		 9.60 5.00 22 21 19 19 11 12 15 15
Net Cash From Financing Activities		 -0.31 0.61 0.11 1.20 1.01 1.31 2.13 4.30 5.52 7.11
Net Cash From Continuing Financing Activities		 -0.31 0.61 0.11 1.20 1.01 1.31 2.13 4.30 5.52 7.11
Other Financing Activities, net		 -0.04 3.65 -2.10 -0.08 -0.09 5.92 -4.90 -0.14 -0.27 24

Annual Balance Sheets for Vericel

This table presents Vericel's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets		 34 49 55 119 153 206 244 273 354 433
Total Current Assets		 27 45 51 113 112 124 158 187 206 213
Cash & Equivalents		 15 23 27 18 27 34 68 51 69 75
Restricted Cash		 - - - - - - - 0.00 18 11
Short-Term Investments		 - - 0.00 65 43 42 35 68 40 42
Accounts Receivable		 11 17 18 23 32 35 37 47 58 61
Inventories, net		 1.38 3.49 3.79 3.56 6.82 9.36 13 16 13 17
Other Current Assets		 0.46 1.16 1.58 2.85 2.95 3.89 4.25 4.80 6.85 7.29
Plant, Property, & Equipment, net		 4.05 3.88 4.07 5.91 0.00 0.00 13 16 42 103
Total Noncurrent Assets		 2.92 0.00 0.00 0.00 42 82 72 70 106 117
Long-Term Investments		 - - - 0.00 9.25 24 26 20 25 40
Intangible Assets		 2.92 - - - - - 0.00 7.50 6.88 6.25
Other Noncurrent Operating Assets		 - - - 0.00 32 58 46 43 74 71
Total Liabilities & Shareholders' Equity		 34 49 55 119 153 206 244 273 354 433
Total Liabilities		 12 24 32 16 42 71 73 81 128 141
Total Current Liabilities		 12 13 13 15 20 22 26 37 46 50
Accounts Payable		 7.59 6.54 5.55 7.11 6.35 6.76 9.02 17 22 24
Accrued Expenses		 3.60 4.52 5.57 6.93 7.95 11 14 16 17 17
Other Current Liabilities		 0.92 1.01 1.20 0.75 5.50 4.44 2.99 4.34 6.19 9.37
Total Noncurrent Liabilities		 0.07 11 19 1.67 22 49 47 43 82 90
Other Noncurrent Operating Liabilities		 0.00 11 19 1.67 22 49 47 43 82 90
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 22 25 23 102 111 134 170 192 226 292
Total Preferred & Common Equity		 22 25 23 102 111 134 170 192 226 292
Total Common Equity		 22 25 23 102 111 134 170 192 226 292
Common Stock		 308 330 383 471 490 510 554 593 629 685
Retained Earnings		 -324 -344 -361 -369 -379 -376 -383 -400 -403 -393
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.19 0.00 -0.04 0.02 0.01 -0.15 -0.98 -0.10 0.00

Quarterly Balance Sheets for Vericel

This table presents Vericel's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets		 248 265 311 318 357 377 390
Total Current Assets		 166 178 183 186 190 197 191
Cash & Equivalents		 65 62 43 60 63 50 54
Restricted Cash		 - - 28 23 7.80 26 17
Short-Term Investments		 46 57 55 45 48 52 48
Accounts Receivable		 34 38 38 40 50 48 48
Inventories, net		 17 15 14 13 14 15 16
Other Current Assets		 4.41 4.54 5.04 5.43 7.78 6.43 7.88
Plant, Property, & Equipment, net		 16 18 23 30 56 73 88
Total Noncurrent Assets		 66 69 104 102 111 106 111
Long-Term Investments		 22 20 21 20 29 26 33
Intangible Assets		 - 7.34 7.19 7.03 6.72 6.56 6.41
Other Noncurrent Operating Assets		 44 42 76 74 74 74 72
Total Liabilities & Shareholders' Equity		 248 265 311 318 357 377 390
Total Liabilities		 70 71 112 114 123 134 133
Total Current Liabilities		 27 29 36 36 36 44 41
Accounts Payable		 8.11 11 14 15 19 25 21
Accrued Expenses		 14 13 14 14 11 13 14
Other Current Liabilities		 4.94 4.52 7.24 7.27 6.01 5.79 6.12
Total Noncurrent Liabilities		 43 42 76 78 86 90 92
Other Noncurrent Operating Liabilities		 43 42 76 78 86 90 92
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 178 194 199 204 234 243 257
Total Preferred & Common Equity		 178 194 199 204 234 243 257
Total Common Equity		 178 194 199 204 234 243 257
Common Stock		 585 602 612 621 641 655 670
Retained Earnings		 -406 -407 -413 -416 -407 -412 -413
Accumulated Other Comprehensive Income / (Loss)		 -1.15 -0.64 -0.62 -0.46 -0.25 -0.27 0.36

Annual Metrics and Ratios for Vericel

This table displays calculated financial ratios and metrics derived from Vericel's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 77.69% 6.28% 17.54% 42.13% 29.71% 5.37% 25.77% 5.24% 20.17% 20.10%
EBITDA Growth		 22.99% -19.61% 16.62% 52.05% -43.46% 149.92% -176.84% -228.83% 81.41% 511.27%
EBIT Growth		 17.91% -19.50% 16.42% 50.06% -38.04% 120.93% -430.73% -117.42% 62.27% 173.66%
NOPAT Growth		 29.16% -15.44% 22.14% 73.91% -187.82% 128.34% -346.35% -117.19% 62.11% 198.47%
Net Income Growth		 17.97% -19.74% 11.65% 52.93% -18.78% 129.63% -360.86% -123.65% 80.96% 425.64%
EPS Growth		 56.50% -21.65% 55.93% 61.54% -10.00% 127.27% -366.67% -118.75% 80.00% 385.71%
Operating Cash Flow Growth		 47.48% -49.05% 33.73% 96.87% -1,643.45% 344.63% 65.26% -39.09% 99.64% 64.72%
Free Cash Flow Firm Growth		 46.05% 40.02% 52.63% -554.34% 20.45% 100.02% -335,131.57% -86.37% -7.50% -89.56%
Invested Capital Growth		 43.83% -66.65% -256.32% 586.08% 66.40% 6.94% 20.44% 27.54% 38.96% 70.92%
Revenue Q/Q Growth		 1.42% 2.07% 11.96% 9.64% 7.34% 4.93% 1.54% 3.20% 6.64% 4.58%
EBITDA Q/Q Growth		 -19.18% -7.80% 30.81% 32.81% 25.28% 86.03% -500.41% 12.56% 74.66% 157.87%
EBIT Q/Q Growth		 -18.30% -7.48% 28.85% 32.39% 30.38% 417.50% -2,442.94% 10.23% 51.26% 561.25%
NOPAT Q/Q Growth		 -18.58% -5.09% 32.09% 55.14% 22.22% 415.66% -5,421.64% 10.23% 50.69% 462.52%
Net Income Q/Q Growth		 -18.41% -7.04% 27.28% 37.85% 30.59% 1,875.17% -3,591.12% 7.66% 68.97% 192.05%
EPS Q/Q Growth		 -67.24% -47.50% 40.91% 39.39% 26.67% 100.00% 0.00% 7.89% 68.18% 150.00%
Operating Cash Flow Q/Q Growth		 14.19% -36.05% 43.48% 81.18% 6.98% 87.23% -2.64% -16.82% 9.66% 26.42%
Free Cash Flow Firm Q/Q Growth		 18.89% 36.29% 78.57% -193.13% -12.18% 100.05% -38.16% -15.49% -27.11% 7.99%
Invested Capital Q/Q Growth		 -1.89% -68.71% -135.38% 37.87% 43.90% 18.10% 8.16% 16.86% 31.62% 18.06%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 48.27% 47.95% 52.52% 64.60% 68.12% 67.83% 67.88% 66.80% 68.64% 72.55%
EBITDA Margin		 -28.88% -32.50% -23.05% -7.78% -8.60% 4.07% -2.49% -7.78% -1.20% 4.12%
Operating Margin		 -32.58% -35.39% -23.44% -4.30% -9.55% 1.91% -5.03% -10.38% -3.27% 1.91%
EBIT Margin		 -31.99% -35.97% -25.57% -8.99% -9.56% 1.90% -5.00% -10.32% -3.24% 1.99%
Profit (Net Income) Margin		 -31.93% -35.98% -27.04% -8.96% -8.20% 2.31% -4.78% -10.17% -1.61% 4.37%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 94.09% 98.54% 104.51% 134.38% 98.59%
Interest Burden Percent		 99.84% 100.04% 105.74% 99.66% 85.75% 129.04% 97.18% 94.25% 37.00% 222.95%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 5.91% 0.00% 0.00% 0.00% 1.41%
Return on Invested Capital (ROIC)		 -180.67% -265.16% 0.00% -35.69% -30.63% 6.71% -14.52% -25.37% -7.18% 4.49%
ROIC Less NNEP Spread (ROIC-NNEP)		 -159.85% -231.93% 0.00% -25.82% -28.41% 6.01% -12.80% -21.81% -8.10% 0.78%
Return on Net Nonoperating Assets (RNNOA)		 124.11% 181.61% 0.00% 22.64% 21.56% -4.38% 9.62% 16.15% 5.65% -0.48%
Return on Equity (ROE)		 -56.57% -83.55% -73.17% -13.04% -9.06% 2.33% -4.90% -9.21% -1.52% 4.00%
Cash Return on Invested Capital (CROIC)		 -216.62% -165.19% 0.00% -134.75% -80.47% 0.01% -33.07% -49.57% -39.79% -47.87%
Operating Return on Assets (OROA)		 -39.97% -47.18% -31.69% -9.42% -8.29% 1.31% -3.47% -6.57% -2.04% 1.20%
Return on Assets (ROA)		 -39.91% -47.20% -33.51% -9.39% -7.11% 1.60% -3.33% -6.47% -1.02% 2.64%
Return on Common Equity (ROCE)		 -56.57% -83.55% -73.17% -13.04% -9.06% 2.33% -4.90% -9.21% -1.52% 4.00%
Return on Equity Simple (ROE_SIMPLE)		 -73.84% -79.19% -76.69% -7.96% -8.70% 2.13% -4.38% -8.69% -1.41% 3.55%
Net Operating Profit after Tax (NOPAT)		 -12 -13 -10 -2.74 -7.88 2.23 -5.50 -12 -4.52 4.46
NOPAT Margin		 -22.81% -24.77% -16.41% -3.01% -6.68% 1.80% -3.52% -7.26% -2.29% 1.88%
Net Nonoperating Expense Percent (NNEP)		 -20.82% -33.23% -27.93% -9.87% -2.21% 0.71% -1.72% -3.55% 0.92% 3.70%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -6.21% -2.00% 1.53%
Cost of Revenue to Revenue		 51.73% 52.05% 47.48% 35.40% 31.88% 32.17% 32.12% 33.20% 31.36% 27.45%
SG&A Expenses to Revenue		 43.93% 50.36% 55.71% 53.94% 51.88% 55.43% 62.49% 65.04% 61.26% 60.19%
R&D to Revenue		 36.92% 28.12% 20.25% 14.97% 25.79% 10.48% 10.43% 12.13% 10.65% 10.45%
Operating Expenses to Revenue		 80.85% 83.34% 75.96% 68.91% 77.67% 65.92% 72.91% 77.17% 71.91% 70.65%
Earnings before Interest and Taxes (EBIT)		 -16 -20 -16 -8.17 -11 2.36 -7.80 -17 -6.40 4.71
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -15 -18 -15 -7.07 -10 5.06 -3.89 -13 -2.38 9.78
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 2.77 2.93 8.44 7.38 7,000.43 10.45 10.79 6.47 7.52 9.28
Price to Tangible Book Value (P/TBV)		 3.19 2.93 8.44 7.38 7,000.43 10.45 10.79 6.73 7.76 9.49
Price to Revenue (P/Rev)		 1.20 1.33 2.98 8.30 6,598.94 11.30 11.78 7.57 8.60 11.42
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 489.82 0.00 0.00 0.00 261.56
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.20% 0.00% 0.00% 0.00% 0.38%
Enterprise Value to Invested Capital (EV/IC)		 6.15 19.74 0.00 34.77 24,204.87 37.93 41.35 20.93 21.09 20.29
Enterprise Value to Revenue (EV/Rev)		 0.92 0.92 2.56 7.39 6,598.27 10.49 10.95 6.72 7.83 10.72
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 257.50 0.00 0.00 0.00 260.19
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 552.33 0.00 0.00 0.00 539.59
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 583.82 0.00 0.00 0.00 570.92
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 74.15 58.91 62.44 43.81 43.73
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 348,639.40 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.03 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.78 -0.78 -1.03 -0.88 -0.76 -0.73 -0.75 -0.74 -0.70 -0.62
Leverage Ratio		 1.42 1.77 2.18 1.39 1.27 1.46 1.47 1.42 1.50 1.52
Compound Leverage Factor		 1.42 1.77 2.31 1.38 1.09 1.89 1.43 1.34 0.55 3.39
Debt to Total Capital		 0.32% 3.18% 1.53% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 3.05% 1.53% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.32% 0.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.68% 96.82% 98.47% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 -0.05 -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.98 1.25 1.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.01 -0.06 -0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 1.24 1.65 2.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -9.75 -7.50 -4.69 24.67 11,068.82 10.47 14.06 8.25 7.43 11.32
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 2.26 3.48 3.86 7.62 5.64 5.50 6.08 4.99 4.49 4.23
Quick Ratio		 2.11 3.12 3.45 7.19 5.15 4.91 5.41 4.43 3.67 3.53
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -14 -8.39 -3.98 -26 -21 0.00 -13 -23 -25 -48
Operating Cash Flow to CapEx		 -549.90% -1,405.80% -873.05% -15.38% -274.58% 669.15% 366.90% 232.85% 176.44% 90.92%
Free Cash Flow to Firm to Interest Expense		 -1,554.63 -559.50 -4.18 -29.94 -2,586.84 0.62 -3,130.20 -63.76 -41.81 -77.45
Operating Cash Flow to Interest Expense		 -1,482.89 -1,326.13 -13.85 -0.47 -897.88 2,928.67 7,260.00 48.33 58.85 94.73
Operating Cash Flow Less CapEx to Interest Expense		 -1,752.56 -1,420.47 -15.43 -3.56 -1,224.88 2,491.00 5,281.25 27.57 25.50 -9.46
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 1.25 1.31 1.24 1.05 0.87 0.69 0.70 0.64 0.63 0.60
Accounts Receivable Turnover		 5.36 3.88 3.62 4.36 4.24 3.73 4.34 3.91 3.77 3.96
Inventory Turnover		 16.05 11.63 8.34 8.75 7.24 4.94 4.41 3.72 4.26 4.28
Fixed Asset Turnover		 14.74 13.73 16.09 18.21 0.00 0.00 0.00 11.28 6.87 3.28
Accounts Payable Turnover		 3.95 4.01 5.02 5.08 5.59 6.10 6.36 4.21 3.15 2.82
Days Sales Outstanding (DSO)		 68.16 94.00 100.96 83.81 86.14 97.98 84.06 93.24 96.92 92.11
Days Inventory Outstanding (DIO)		 22.75 31.38 43.78 41.72 50.39 73.88 82.73 98.20 85.66 85.37
Days Payable Outstanding (DPO)		 92.47 91.05 72.67 71.84 65.35 59.84 57.38 86.76 115.73 129.47
Cash Conversion Cycle (CCC)		 -1.57 34.33 72.06 53.68 71.18 112.02 109.41 104.68 66.86 48.01
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 7.62 2.54 -3.97 19 32 34 41 53 73 125
Invested Capital Turnover		 7.92 10.70 -89.34 11.85 4.58 3.74 4.12 3.49 3.13 2.39
Increase / (Decrease) in Invested Capital		 2.32 -5.08 -6.51 23 13 2.23 7.02 11 21 52
Enterprise Value (EV)		 47 50 164 671 777,606 1,303 1,711 1,104 1,547 2,544
Market Capitalization		 61 72 190 754 777,685 1,403 1,840 1,244 1,699 2,710
Book Value per Share		 $0.93 $1.02 $0.65 $2.36 $0.00 $2.96 $3.64 $4.07 $4.73 $5.92
Tangible Book Value per Share		 $0.81 $1.02 $0.65 $2.36 $0.00 $2.96 $3.64 $3.91 $4.59 $5.79
Total Capital		 22 26 23 102 111 134 170 192 226 292
Total Debt		 0.07 0.81 0.35 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.07 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -15 -22 -27 -83 -79 -100 -129 -140 -153 -167
Capital Expenditures (CapEx)		 2.43 1.42 1.51 2.68 2.62 2.63 7.92 7.60 20 64
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.65 9.67 11 15 22 25 29 30 33 36
Debt-free Net Working Capital (DFNWC)		 15 33 38 98 92 101 132 149 160 162
Net Working Capital (NWC)		 15 32 37 98 92 101 132 149 160 162
Net Nonoperating Expense (NNE)		 4.67 6.09 6.80 5.40 1.79 -0.63 1.97 4.77 -1.34 -5.91
Net Nonoperating Obligations (NNO)		 -15 -22 -27 -83 -79 -100 -129 -140 -153 -167
Total Depreciation and Amortization (D&A)		 1.59 1.89 1.61 1.10 1.13 2.70 3.91 4.18 4.02 5.06
Debt-free, Cash-free Net Working Capital to Revenue		 1.28% 17.78% 17.06% 16.58% 18.79% 20.35% 18.58% 18.17% 16.48% 15.07%
Debt-free Net Working Capital to Revenue		 29.77% 60.04% 59.08% 107.85% 77.95% 81.40% 84.78% 90.90% 80.95% 68.50%
Net Working Capital to Revenue		 29.77% 58.60% 58.53% 107.85% 77.95% 81.40% 84.78% 90.90% 80.95% 68.50%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.97) ($1.18) ($0.52) $0.00 ($0.22) $0.06 ($0.16) ($0.35) ($0.07) $0.21
Adjusted Weighted Average Basic Shares Outstanding		 23.85M 32.72M 36.10M 43.75M 44.95M 45.22M 46.47M 47.13M 47.59M 48.85M
Adjusted Diluted Earnings per Share		 ($0.97) ($1.18) ($0.52) $0.00 ($0.22) $0.06 ($0.16) ($0.35) ($0.07) $0.20
Adjusted Weighted Average Diluted Shares Outstanding		 23.85M 32.72M 36.10M 43.75M 44.95M 47.28M 46.47M 47.13M 47.59M 51.68M
Adjusted Basic & Diluted Earnings per Share		 ($0.97) ($1.18) ($0.52) $0.00 ($0.22) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 23.76M 23.09M 33.36M 40.24M 44.18M 45.95M 46.97M 47.36M 48.29M 49.97M
Normalized Net Operating Profit after Tax (NOPAT)		 -12 -12 -10 -2.74 -7.88 2.23 -5.50 -12 -4.52 4.46
Normalized NOPAT Margin		 -22.81% -21.38% -16.41% -3.01% -6.68% 1.80% -3.52% -7.26% -2.29% 1.88%
Pre Tax Income Margin		 -31.93% -35.98% -27.04% -8.96% -8.20% 2.45% -4.85% -9.73% -1.20% 4.43%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -1,818.56 -1,303.93 -17.17 -9.40 -1,408.88 393.17 -1,950.50 -46.35 -10.67 7.68
NOPAT to Interest Expense		 -1,296.63 -898.10 -11.02 -3.15 -984.46 371.96 -1,374.45 -32.62 -7.54 7.26
EBIT Less CapEx to Interest Expense		 -2,088.22 -1,398.27 -18.76 -12.48 -1,735.88 -44.50 -3,929.25 -67.10 -44.02 -96.51
NOPAT Less CapEx to Interest Expense		 -1,566.30 -992.43 -12.60 -6.23 -1,311.46 -65.71 -3,353.20 -53.38 -40.90 -96.94
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Vericel

This table displays calculated financial ratios and metrics derived from Vericel's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 11.72% 10.72% 13.70% 23.96% 18.24% 23.35% 25.02% 14.68% 27.04% 15.97%
EBITDA Growth		 -41.27% 35.71% -19.25% 37.50% 27.96% 100.37% 43.02% 0.61% 72.84% 42.81%
EBIT Growth		 -36.57% 46.59% -14.36% 34.37% 25.54% 110.67% 33.19% -1.22% 54.03% 44.77%
NOPAT Growth		 -36.83% 36.38% -12.43% 34.36% 25.50% 109.22% 33.18% -1.17% 51.26% 45.15%
Net Income Growth		 -33.38% 30.58% -5.70% 43.99% 44.35% 119.40% 48.47% 6.73% 75.38% 52.44%
EPS Growth		 -27.27% 30.00% -6.67% 42.11% 42.86% 115.38% 50.00% 9.09% 75.00% 42.86%
Operating Cash Flow Growth		 12.85% -33.89% 126.64% 224.40% 74.81% 44.60% -8.37% 81.79% 42.06% 120.52%
Free Cash Flow Firm Growth		 7.78% -107.32% 51.76% 69.74% -20.97% -47.48% -207.92% -535.61% -270.08% -328.20%
Invested Capital Growth		 18.05% 27.54% 11.51% 4.45% 23.38% 38.96% 56.98% 69.70% 90.56% 70.92%
Revenue Q/Q Growth		 4.06% 36.69% -22.16% 11.96% -0.74% 42.59% -21.10% 2.69% 9.96% 30.17%
EBITDA Q/Q Growth		 27.60% 221.55% -204.16% 31.82% 16.55% 438.09% -129.62% -18.93% 77.20% 1,877.83%
EBIT Q/Q Growth		 25.28% 189.53% -234.64% 27.15% 15.22% 353.32% -142.70% -10.38% 61.50% 897.81%
NOPAT Q/Q Growth		 25.26% 228.06% -194.07% 27.10% 15.17% 459.64% -130.04% -10.38% 59.13% 1,170.94%
Net Income Q/Q Growth		 26.62% 190.04% -226.56% 33.02% 27.09% 455.00% -129.72% -21.23% 80.76% 2,298.34%
EPS Q/Q Growth		 26.32% 192.86% -223.08% 31.25% 27.27% 450.00% -128.57% -25.00% 80.00% 2,100.00%
Operating Cash Flow Q/Q Growth		 30.48% 70.08% 12.69% 29.72% -29.69% 40.69% -28.59% 157.36% -45.06% 118.40%
Free Cash Flow Firm Q/Q Growth		 44.90% 54.44% -114.33% 43.75% -120.25% 44.46% -347.50% -16.11% -28.24% 35.74%
Invested Capital Q/Q Growth		 -9.84% 16.86% 3.83% -4.52% 6.50% 31.62% 17.29% 3.23% 19.58% 18.06%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 65.45% 72.59% 64.66% 65.20% 67.15% 74.63% 68.94% 69.50% 71.93% 77.61%
EBITDA Margin		 -14.89% 13.24% -17.72% -10.79% -9.07% 21.51% -8.08% -9.35% -1.94% 26.49%
Operating Margin		 -17.61% 11.55% -19.94% -12.98% -11.09% 19.59% -10.66% -11.45% -4.26% 24.52%
EBIT Margin		 -17.62% 11.54% -19.96% -12.99% -11.10% 19.71% -10.67% -11.47% -4.02% 24.61%
Profit (Net Income) Margin		 -17.06% 11.24% -18.27% -10.93% -8.03% 19.99% -7.53% -8.89% -1.56% 26.28%
Tax Burden Percent		 100.32% 89.43% 100.00% 100.00% 92.75% 92.19% 100.00% 100.00% 100.00% 99.26%
Interest Burden Percent		 96.51% 108.88% 91.53% 84.14% 78.02% 109.99% 70.59% 77.53% 38.75% 107.58%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -47.07% 40.32% -45.47% -31.62% -28.52% 61.36% -22.01% -24.38% -8.35% 58.54%
ROIC Less NNEP Spread (ROIC-NNEP)		 -45.61% 40.44% -44.12% -31.00% -28.43% 61.18% -21.99% -24.07% -8.90% 57.71%
Return on Net Nonoperating Assets (RNNOA)		 34.24% -29.94% 31.61% 22.50% 20.93% -42.73% 14.75% 16.38% 5.78% -35.57%
Return on Equity (ROE)		 -12.82% 10.38% -13.86% -9.12% -7.59% 18.63% -7.26% -7.99% -2.57% 22.97%
Cash Return on Invested Capital (CROIC)		 -48.45% -49.57% -35.08% -24.64% -39.13% -39.79% -49.67% -57.11% -63.85% -47.87%
Operating Return on Assets (OROA)		 -11.89% 7.34% -13.38% -8.33% -7.26% 12.43% -7.13% -7.16% -2.57% 14.85%
Return on Assets (ROA)		 -11.51% 7.15% -12.24% -7.01% -5.25% 12.60% -5.03% -5.55% -1.00% 15.85%
Return on Common Equity (ROCE)		 -12.82% 10.38% -13.86% -9.12% -7.59% 18.63% -7.26% -7.99% -2.57% 22.97%
Return on Equity Simple (ROE_SIMPLE)		 -10.18% 0.00% -8.82% -6.62% -5.02% 0.00% 0.19% 0.32% 1.38% 0.00%
Net Operating Profit after Tax (NOPAT)		 -4.75 6.09 -5.72 -4.17 -3.54 13 -3.82 -4.22 -1.73 18
NOPAT Margin		 -12.33% 11.55% -13.95% -9.09% -7.77% 19.59% -7.46% -8.02% -2.98% 24.52%
Net Nonoperating Expense Percent (NNEP)		 -1.45% -0.12% -1.35% -0.62% -0.09% 0.18% -0.03% -0.31% 0.55% 0.83%
Return On Investment Capital (ROIC_SIMPLE)		 - 3.16% - - - 5.63% - - - 6.33%
Cost of Revenue to Revenue		 34.55% 27.41% 35.34% 34.80% 32.85% 25.37% 31.06% 30.50% 28.07% 22.39%
SG&A Expenses to Revenue		 69.97% 51.09% 71.88% 66.74% 65.79% 47.50% 67.08% 66.97% 65.67% 46.56%
R&D to Revenue		 13.09% 9.95% 12.71% 11.44% 12.45% 7.54% 12.52% 13.98% 10.52% 6.53%
Operating Expenses to Revenue		 83.06% 61.04% 84.59% 78.18% 78.25% 55.04% 79.60% 80.95% 76.19% 53.09%
Earnings before Interest and Taxes (EBIT)		 -6.79 6.08 -8.19 -5.97 -5.06 13 -5.47 -6.04 -2.33 19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -5.74 6.98 -7.27 -4.96 -4.14 14 -4.14 -4.93 -1.12 20
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 6.15 6.47 7.16 8.98 7.81 7.52 10.74 9.18 8.05 9.28
Price to Tangible Book Value (P/TBV)		 6.15 6.73 7.44 9.32 8.09 7.76 11.06 9.43 8.25 9.49
Price to Revenue (P/Rev)		 6.87 7.57 8.20 10.03 8.62 8.60 12.09 10.39 9.13 11.42
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 5,569.97 2,826.17 583.86 261.56
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.04% 0.17% 0.38%
Enterprise Value to Invested Capital (EV/IC)		 21.30 20.93 22.81 31.35 25.99 21.09 27.49 23.38 18.09 20.29
Enterprise Value to Revenue (EV/Rev)		 6.04 6.72 7.38 9.21 7.82 7.83 11.38 9.68 8.47 10.72
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 3,156.43 2,664.51 506.52 260.19
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 539.59
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 570.92
Enterprise Value to Operating Cash Flow (EV/OCF)		 45.24 62.44 56.59 56.31 44.98 43.81 68.22 48.28 41.74 43.73
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.75 -0.74 -0.72 -0.73 -0.74 -0.70 -0.67 -0.68 -0.65 -0.62
Leverage Ratio		 1.41 1.42 1.38 1.49 1.48 1.50 1.45 1.56 1.53 1.52
Compound Leverage Factor		 1.36 1.55 1.26 1.25 1.16 1.65 1.03 1.21 0.59 1.63
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 8.29 8.53 10.77 8.81 7.69 7.61 11.73 9.47 8.89 11.42
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 6.16 4.99 6.17 5.14 5.18 4.49 5.20 4.50 4.61 4.23
Quick Ratio		 5.38 4.43 5.48 3.82 4.04 3.67 4.40 3.43 3.63 3.53
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -12 -5.31 -11 -6.40 -14 -7.83 -35 -41 -52 -34
Operating Cash Flow to CapEx		 291.06% 620.00% 556.26% 242.99% 109.13% 128.73% 51.38% 110.58% 52.47% 161.33%
Free Cash Flow to Firm to Interest Expense		 -111.01 -23.81 -78.49 -42.96 -94.00 -50.20 -229.04 -265.95 -338.84 -217.74
Operating Cash Flow to Interest Expense		 39.06 31.28 54.21 68.43 47.79 64.65 47.07 121.14 66.13 144.43
Operating Cash Flow Less CapEx to Interest Expense		 25.64 26.23 44.46 40.27 4.00 14.43 -44.54 11.59 -59.90 54.90
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.67 0.64 0.67 0.64 0.65 0.63 0.67 0.62 0.64 0.60
Accounts Receivable Turnover		 5.04 3.91 4.82 4.95 5.00 3.77 4.71 4.97 5.14 3.96
Inventory Turnover		 3.60 3.72 3.79 3.91 4.08 4.26 4.38 4.41 4.56 4.28
Fixed Asset Turnover		 0.00 11.28 10.37 0.00 8.03 6.87 5.57 4.45 3.82 3.28
Accounts Payable Turnover		 7.85 4.21 5.98 4.84 5.17 3.15 4.15 3.20 3.60 2.82
Days Sales Outstanding (DSO)		 72.43 93.24 75.68 73.73 72.94 96.92 77.55 73.43 70.96 92.11
Days Inventory Outstanding (DIO)		 101.25 98.20 96.19 93.42 89.43 85.66 83.31 82.75 80.01 85.37
Days Payable Outstanding (DPO)		 46.53 86.76 61.02 75.47 70.58 115.73 88.00 113.95 101.32 129.47
Cash Conversion Cycle (CCC)		 127.15 104.68 110.86 91.67 91.79 66.86 72.86 42.23 49.66 48.01
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 45 53 55 52 56 73 86 89 106 125
Invested Capital Turnover		 3.82 3.49 3.26 3.48 3.67 3.13 2.95 3.04 2.80 2.39
Increase / (Decrease) in Invested Capital		 6.90 11 5.66 2.23 11 21 31 36 50 52
Enterprise Value (EV)		 962 1,104 1,250 1,640 1,448 1,547 2,364 2,076 1,920 2,544
Market Capitalization		 1,095 1,244 1,389 1,787 1,597 1,699 2,512 2,230 2,072 2,710
Book Value per Share		 $3.77 $4.07 $4.10 $4.18 $4.29 $4.73 $4.84 $5.00 $5.25 $5.92
Tangible Book Value per Share		 $3.77 $3.91 $3.94 $4.03 $4.14 $4.59 $4.70 $4.86 $5.12 $5.79
Total Capital		 178 192 194 199 204 226 234 243 257 292
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -133 -140 -139 -147 -149 -153 -148 -154 -151 -167
Capital Expenditures (CapEx)		 1.41 1.13 1.41 4.20 6.57 7.84 14 17 19 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 28 30 30 22 22 33 35 25 31 36
Debt-free Net Working Capital (DFNWC)		 139 149 149 147 150 160 153 154 149 162
Net Working Capital (NWC)		 139 149 149 147 150 160 153 154 149 162
Net Nonoperating Expense (NNE)		 1.83 0.16 1.77 0.85 0.12 -0.26 0.04 0.46 -0.82 -1.33
Net Nonoperating Obligations (NNO)		 -133 -140 -139 -147 -149 -153 -148 -154 -151 -167
Total Depreciation and Amortization (D&A)		 1.05 0.90 0.92 1.01 0.92 1.17 1.33 1.11 1.20 1.42
Debt-free, Cash-free Net Working Capital to Revenue		 17.85% 18.17% 17.43% 12.14% 11.79% 16.48% 16.75% 11.86% 13.56% 15.07%
Debt-free Net Working Capital to Revenue		 87.51% 90.90% 87.88% 82.64% 81.13% 80.95% 73.75% 71.57% 65.76% 68.50%
Net Working Capital to Revenue		 87.51% 90.90% 87.88% 82.64% 81.13% 80.95% 73.75% 71.57% 65.76% 68.50%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.14) $0.13 ($0.16) ($0.11) ($0.08) $0.28 ($0.08) ($0.10) ($0.02) $0.41
Adjusted Weighted Average Basic Shares Outstanding		 47.18M 47.13M 47.39M 47.57M 47.65M 47.59M 48.14M 48.69M 49.09M 48.85M
Adjusted Diluted Earnings per Share		 ($0.14) $0.13 ($0.16) ($0.11) ($0.08) $0.28 ($0.08) ($0.10) ($0.02) $0.40
Adjusted Weighted Average Diluted Shares Outstanding		 47.18M 47.13M 47.39M 47.57M 47.65M 47.59M 48.14M 48.69M 49.09M 51.68M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 47.22M 47.36M 47.56M 47.64M 47.72M 48.29M 48.60M 49.03M 49.36M 49.97M
Normalized Net Operating Profit after Tax (NOPAT)		 -4.75 4.26 -5.72 -4.17 -3.54 8.91 -3.82 -4.22 -1.73 13
Normalized NOPAT Margin		 -12.33% 8.08% -13.95% -9.09% -7.77% 13.71% -7.46% -8.02% -2.98% 17.16%
Pre Tax Income Margin		 -17.01% 12.57% -18.27% -10.93% -8.66% 21.68% -7.53% -8.89% -1.56% 26.47%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -64.70 27.27 -56.48 -40.04 -33.72 82.13 -35.76 -39.47 -15.10 120.45
NOPAT to Interest Expense		 -45.25 27.29 -39.48 -28.00 -23.60 81.61 -25.00 -27.59 -11.20 119.99
EBIT Less CapEx to Interest Expense		 -78.11 22.23 -66.22 -68.20 -77.51 31.91 -127.37 -149.02 -141.13 30.92
NOPAT Less CapEx to Interest Expense		 -58.67 22.24 -49.22 -56.17 -67.39 31.38 -116.61 -137.14 -137.24 30.47
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Vericel's Financials

When does Vericel's financial year end?

According to the most recent income statement we have on file, Vericel's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Vericel's net income changed over the last 9 years?

Vericel's net income appears to be on a downward trend, with a most recent value of $10.36 million in 2024, falling from -$16.34 million in 2015. The previous period was -$3.18 million in 2023.

What is Vericel's operating income?
Vericel's total operating income in 2024 was $4.52 million, based on the following breakdown:
  • Total Gross Profit: $172.11 million
  • Total Operating Expenses: $167.59 million
How has Vericel revenue changed over the last 9 years?

Over the last 9 years, Vericel's total revenue changed from $51.17 million in 2015 to $237.22 million in 2024, a change of 363.6%.

How much debt does Vericel have?

Vericel's total liabilities were at $140.76 million at the end of 2024, a 10.2% increase from 2023, and a 1,055.7% increase since 2015.

How much cash does Vericel have?

In the past 9 years, Vericel's cash and equivalents has ranged from $14.58 million in 2015 to $74.52 million in 2024, and is currently $74.52 million as of their latest financial filing in 2024.

How has Vericel's book value per share changed over the last 9 years?

Over the last 9 years, Vericel's book value per share changed from 0.93 in 2015 to 5.92 in 2024, a change of 535.8%.

Remove Ads

Related Companies

This page (NASDAQ:VCEL) was last updated on 4/10/2025 by MarketBeat.com Staff
From Our Partners
Trump’s policies mean HUGE income for investors
Thanks to a Trump win… Investors have a HUGE opportunity at new income. The floodgates for U.S. oil prod...
The Oxford Club | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Feds Just Admitted It—They Can Take Your Cash
The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...
Priority Gold | Sponsored
Trump Orders 'National Digital Asset Stockpile'
‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more traction
Crypto 101 Media | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
This almost killed Elon Musk (chilling details emerge)
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...
Colonial Metals | Sponsored
Elon Musk is helping print “new gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored